Search Results 2331-2340 of 32780 for cesarean section

  1. Mayo Clinic Transplant Center - Doctors

    C. Burcin Taner, M.D.. General Surgeon. Jacksonville, FL. Areas of focus: Liver transplant ...

  2. Surgery - Doctors - Mayo Clinic

    Frozen Section Pathology Lab. Doctors. Mayo Clinic ... Find a doctor whose last name begins with the letter C C ... Paul C. Tang ...

  3. Head and Neck Cancer Center - Doctors - Mayo Clinic

    Scott C. Lester, M.D.. Radiation Oncologist. Rochester, MN. Areas of focus: Radiation therapy, Proton ...

  4. Vaginal tears in childbirth - Mayo Clinic

    That area is called the perineum. First-degree tears also may happen ... Repeat C-sections · Signs of labor: Know what to expect · Stages of labor and ...

  5. Department and Faculty - Vascular Surgery Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Academics Section Overview. Academic programs. Residencies and fellowships. 350+ GME programs in all medical and surgical specialties. Health sciences education.

  6. Cardiovascular Medicine - Doctors - Mayo Clinic

    Vlad C. Vasile, M.D., Ph.D. Cardiologist. Rochester, MN ...

  7. Incompetent cervix - Diagnosis and treatment - Mayo Clinic

    A history of painless widening of the cervix, known as dilation, and second trimester delivery during a past pregnancy. Advanced cervical dilation and ...

  8. A Study to Evaluate the Safety,Usability and Compliance of Using C-Scan System for Providing Information on Colonic Polypoid Lesions and Masses - Mayo Clinic

    Clinical Trials · Sections · Find Clinical Trials ... A Study to Evaluate the Safety,Usability and Compliance of Using C-Scan System for Providing Information on ...

  9. Hypothyroidism (underactive thyroid) - Doctors and departments - Mayo Clinic

    Find a doctor whose last name begins with the letter C C ... Zaraq Khan, M.D.. Gynecologist; Reproductive Endocrinologist. Rochester, MN. Areas of focus: Birth ...

  10. Elotuzumab In Immunoglobulin G4-Related Disease (IgG4-RD) - Mayo Clinic

    This is a two-part multi-center clinical trial in participants with active IgG4-RD. Part 1 is an open-label, dose escalation phase to determine the safety of ...